These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1054 related articles for article (PubMed ID: 25498306)
21. Self-assembled pH-responsive hyaluronic acid-g-poly((L)-histidine) copolymer micelles for targeted intracellular delivery of doxorubicin. Qiu L; Li Z; Qiao M; Long M; Wang M; Zhang X; Tian C; Chen D Acta Biomater; 2014 May; 10(5):2024-35. PubMed ID: 24365705 [TBL] [Abstract][Full Text] [Related]
22. Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor. Lee ES; Na K; Bae YH J Control Release; 2005 Mar; 103(2):405-18. PubMed ID: 15763623 [TBL] [Abstract][Full Text] [Related]
23. Targeted doxorubicin nanotherapy strongly suppressing growth of multidrug resistant tumor in mice. Nguyen DH; Lee JS; Bae JW; Choi JH; Lee Y; Son JY; Park KD Int J Pharm; 2015 Nov; 495(1):329-335. PubMed ID: 26325307 [TBL] [Abstract][Full Text] [Related]
24. pH-responsive polymeric micelles based on poly(2-ethyl-2-oxazoline)-poly(D,L-lactide) for tumor-targeting and controlled delivery of doxorubicin and P-glycoprotein inhibitor. Zhao Y; Zhou Y; Wang D; Gao Y; Li J; Ma S; Zhao L; Zhang C; Liu Y; Li X Acta Biomater; 2015 Apr; 17():182-92. PubMed ID: 25612838 [TBL] [Abstract][Full Text] [Related]
25. Delivery of mitochondriotropic doxorubicin derivatives using self-assembling hyaluronic acid nanocarriers in doxorubicin-resistant breast cancer. Liu HN; Guo NN; Guo WW; Huang-Fu MY; Vakili MR; Chen JJ; Xu WH; Wei QC; Han M; Lavasanifar A; Gao JQ Acta Pharmacol Sin; 2018 Oct; 39(10):1681-1692. PubMed ID: 29849132 [TBL] [Abstract][Full Text] [Related]
26. Systematic evaluation of multifunctional paclitaxel-loaded polymeric mixed micelles as a potential anticancer remedy to overcome multidrug resistance. Zhang J; Zhao X; Chen Q; Yin X; Xin X; Li K; Qiao M; Hu H; Chen D; Zhao X Acta Biomater; 2017 Mar; 50():381-395. PubMed ID: 27956367 [TBL] [Abstract][Full Text] [Related]
27. Gambogic acid-loaded pH-sensitive mixed micelles for overcoming breast cancer resistance. Wang S; Yang Y; Wang Y; Chen M Int J Pharm; 2015 Nov; 495(2):840-8. PubMed ID: 26407923 [TBL] [Abstract][Full Text] [Related]
28. Biodegradable mixed MPEG-SS-2SA/TPGS micelles for triggered intracellular release of paclitaxel and reversing multidrug resistance. Dong K; Yan Y; Wang P; Shi X; Zhang L; Wang K; Xing J; Dong Y Int J Nanomedicine; 2016; 11():5109-5123. PubMed ID: 27785018 [TBL] [Abstract][Full Text] [Related]
29. Synergistic effects of antitumor efficacy via mixed nano-size micelles of multifunctional Bletilla striata polysaccharide-based copolymer and D-α-tocopheryl polyethylene glycol succinate. Liu Y; Wu J; Huang L; Qiao J; Wang N; Yu D; Zhang G; Yu S; Guan Q Int J Biol Macromol; 2020 Jul; 154():499-510. PubMed ID: 32194114 [TBL] [Abstract][Full Text] [Related]
30. Combination Therapy of Doxorubicin and Quercetin on Multidrug-Resistant Breast Cancer and Their Sequential Delivery by Reduction-Sensitive Hyaluronic Acid-Based Conjugate/d-α-Tocopheryl Poly(ethylene glycol) 1000 Succinate Mixed Micelles. Liu S; Li R; Qian J; Sun J; Li G; Shen J; Xie Y Mol Pharm; 2020 Apr; 17(4):1415-1427. PubMed ID: 32159961 [TBL] [Abstract][Full Text] [Related]
31. Mitochondria-targeted delivery of doxorubicin to enhance antitumor activity with HER-2 peptide-mediated multifunctional pH-sensitive DQAsomes. Shi M; Zhang J; Li X; Pan S; Li J; Yang C; Hu H; Qiao M; Chen D; Zhao X Int J Nanomedicine; 2018; 13():4209-4226. PubMed ID: 30140154 [TBL] [Abstract][Full Text] [Related]
32. Mixed micelles for encapsulation of doxorubicin with enhanced in vitro cytotoxicity on breast and ovarian cancer cell lines versus Doxil Cagel M; Bernabeu E; Gonzalez L; Lagomarsino E; Zubillaga M; Moretton MA; Chiappetta DA Biomed Pharmacother; 2017 Nov; 95():894-903. PubMed ID: 28903185 [TBL] [Abstract][Full Text] [Related]
33. Rational Design of Multifunctional Polymeric Nanoparticles Based on Poly(l-histidine) and d-α-Vitamin E Succinate for Reversing Tumor Multidrug Resistance. Li Z; Chen Q; Qi Y; Liu Z; Hao T; Sun X; Qiao M; Ma X; Xu T; Zhao X; Yang C; Chen D Biomacromolecules; 2018 Jul; 19(7):2595-2609. PubMed ID: 29618203 [TBL] [Abstract][Full Text] [Related]
34. Amphiphilic Copolymeric Micelles for Doxorubicin and Curcumin Co-Delivery to Reverse Multidrug Resistance in Breast Cancer. Lv L; Qiu K; Yu X; Chen C; Qin F; Shi Y; Ou J; Zhang T; Zhu H; Wu J; Liu C; Li G J Biomed Nanotechnol; 2016 May; 12(5):973-85. PubMed ID: 27305819 [TBL] [Abstract][Full Text] [Related]
35. A glutathione-responsive sulfur dioxide polymer prodrug as a nanocarrier for combating drug-resistance in cancer chemotherapy. Shen W; Liu W; Yang H; Zhang P; Xiao C; Chen X Biomaterials; 2018 Sep; 178():706-719. PubMed ID: 29433753 [TBL] [Abstract][Full Text] [Related]
36. Dual-responsive TPGS crosslinked nanocarriers to overcome multidrug resistance. Li L; Liu T; Liao JX; Zhang ZY; Song DB; Wang GH J Mater Chem B; 2020 Sep; 8(36):8383-8394. PubMed ID: 32803210 [TBL] [Abstract][Full Text] [Related]
37. Doxorubicin and lapatinib combination nanomedicine for treating resistant breast cancer. Wang H; Li F; Du C; Wang H; Mahato RI; Huang Y Mol Pharm; 2014 Aug; 11(8):2600-11. PubMed ID: 24405470 [TBL] [Abstract][Full Text] [Related]
39. Acid-activatable prodrug nanogels for efficient intracellular doxorubicin release. Zhan F; Chen W; Wang Z; Lu W; Cheng R; Deng C; Meng F; Liu H; Zhong Z Biomacromolecules; 2011 Oct; 12(10):3612-20. PubMed ID: 21905663 [TBL] [Abstract][Full Text] [Related]
40. Redox-Responsive Polyphosphoester-Based Micellar Nanomedicines for Overriding Chemoresistance in Breast Cancer Cells. Ma YC; Wang JX; Tao W; Sun CY; Wang YC; Li DD; Fan F; Qian HS; Yang XZ ACS Appl Mater Interfaces; 2015 Dec; 7(47):26315-25. PubMed ID: 26552849 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]